Literature DB >> 14717955

Fabry disease: kidney involvement and enzyme replacement therapy.

Kostas C Siamopoulos1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14717955     DOI： 10.1111/j.1523-1755.2004.00440.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  4 in total

1.  Nephropathology quiz page. Heterozygous Fabry's disease.

Authors:  Helen Liapsis
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

Review 2.  Agalsidase Beta: a review of its use in the management of Fabry disease.

Authors:  Gillian M Keating; Dene Simpson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Non-invasive high-risk screening for Fabry disease hemizygotes and heterozygotes.

Authors:  Teruo Kitagawa; Ken Suzuki; Nobuyuki Ishige; Toya Ohashi; Masahisa Kobayashi; Yoshikatsu Eto; Akemi Tanaka; Hideo Odaka; Misao Owada
Journal:  Pediatr Nephrol       Date:  2008-06-06       Impact factor: 3.714

Review 4.  Fabry disease in the era of enzyme replacement therapy: a renal perspective.

Authors:  Monique E Cho; Jeffrey B Kopp
Journal:  Pediatr Nephrol       Date:  2004-04-03       Impact factor: 3.714
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.